Related Experiment Video
Updated: Mar 25, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in
Dongmei Fan1, Ying Wang2, Pengwei Qi1
1Gynaecology and Obstetrics Department of the First Affiliated Hospital of Henan University of Science and Technology, No. 24 Jinghua Road, Luoyang, Henan 471003, China.
Objective:
MicroRNAs have been reported to play an important role in the invasion and metastasis of cervical cancer. miR-183 was found to inhibit or promote the invasion and metastasis of multiple solid tumors. However, the roles of miR-183 in cervical cancer are unclear.
Methods:
In this study, miR-183 expression levels were measured in 53 cervical cancer and 13 normal cervical tissues by qRT-PCR. The effects of forced expression of miR-183 on cervical cancer cells invasion and metastasis were investigated using Transwell uncoated or coated with growth factor-reduced Matrigel for migration or invasion assays, respectively.
Results:
We found that miR-183 expression levels were significantly down-regulated in cervical cancer tissues compared with normal tissues (0.15±0.011 to 0.86±0.049). Ectopic expression of miR-183 resulted in the suppression of invasion and migration of cervical cancer cell lines, siha and Hela cells (p<0.0001). Bioinformatics analysis revealed that MMP-9 was the potential target of miR-183 and it was found that MMP-9 was remarkably up-regulated in cervical cancer. Furthermore, a dual-luciferase reporter assay showed that MMP-9 as a target of miR-183 (p<0.0001). The invasion and metastasis ability of siha and Hela was suppressed when MMP-9 was down-regulated in vitro (p<0.0001).
Conclusions:
In conclusion, our study revealed that miR-183 might be a tumor suppressor via inhibiting the invasion and metastasis of cervical cancer cells through targeting MMP-9, indicating that miR-183 may be a novel potential therapeutic target for cervical cancer.
Insights
MicroRNA-183 (miR-183) is downregulated in cervical cancer, inhibiting tumor cell invasion and metastasis. Targeting MMP-9, miR-183 acts as a tumor suppressor, offering a potential therapeutic strategy for cervical cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs regulate gene expression and are implicated in cancer progression.
- The specific role of miR-183 in cervical cancer invasion and metastasis remains unclear.
- miR-183 has shown varied effects in different solid tumors.
Purpose of the Study:
- To investigate the expression levels of miR-183 in cervical cancer tissues.
- To determine the functional role of miR-183 in the invasion and metastasis of cervical cancer cells.
- To identify potential molecular targets of miR-183 in cervical cancer.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to measure miR-183 expression in 53 cervical cancer and 13 normal tissues.
- Transwell assays (uncoated and Matrigel-coated) to assess cell migration and invasion after forced miR-183 expression.
- Bioinformatics analysis and dual-luciferase reporter assays to identify and validate MMP-9 as a direct target of miR-183.
Main Results:
- miR-183 expression was significantly downregulated in cervical cancer tissues compared to normal tissues.
- Forced expression of miR-183 suppressed the invasion and migration of cervical cancer cell lines (siha and Hela).
- MMP-9 was identified as a direct target of miR-183 and was found to be upregulated in cervical cancer; its downregulation inhibited cancer cell invasion and metastasis.
Conclusions:
- miR-183 functions as a tumor suppressor in cervical cancer by inhibiting cell invasion and metastasis.
- The tumor-suppressive role of miR-183 is mediated through the targeting of MMP-9.
- miR-183 represents a potential novel therapeutic target for cervical cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Abnormal Proliferation

